Harpoon: Merck's $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted [...]
Read full article »
CEO
- -Harpoon is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases.
Read more